Dimensional Fund Advisors LP raised its position in shares of Xylem Inc. (NYSE:XYL) by 0.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,008,168 shares of the company’s stock after buying an additional 1,441 shares during the period. Dimensional Fund Advisors LP owned 0.56% of Xylem worth $45,010,000 as of its most recent filing with the SEC.
Several other hedge funds have also modified their holdings of XYL. Teacher Retirement System of Texas increased its stake in shares of Xylem by 170.0% in the second quarter. Teacher Retirement System of Texas now owns 781,005 shares of the company’s stock worth $34,872,000 after buying an additional 491,739 shares during the period. Impax Asset Management LTD increased its stake in shares of Xylem by 2.4% in the second quarter. Impax Asset Management LTD now owns 2,295,661 shares of the company’s stock worth $102,502,000 after buying an additional 52,972 shares during the period. Eaton Vance Management increased its stake in shares of Xylem by 179.1% in the second quarter. Eaton Vance Management now owns 14,624 shares of the company’s stock worth $653,000 after buying an additional 9,384 shares during the period. Stellar Capital Management LLC increased its stake in shares of Xylem by 1.5% in the second quarter. Stellar Capital Management LLC now owns 34,605 shares of the company’s stock worth $1,545,000 after buying an additional 515 shares during the period. Finally, Delaney Dennis R increased its stake in shares of Xylem by 0.3% in the second quarter. Delaney Dennis R now owns 6,007 shares of the company’s stock worth $269,000 after buying an additional 20 shares during the period. Hedge funds and other institutional investors own 84.70% of the company’s stock.
Xylem Inc. (NYSE:XYL) traded down 1.666% during trading on Thursday, hitting $49.275. The stock had a trading volume of 137,167 shares. Xylem Inc. has a 12 month low of $31.67 and a 12 month high of $53.25. The stock has a 50 day moving average price of $50.96 and a 200-day moving average price of $46.37. The stock has a market cap of $8.83 billion, a price-to-earnings ratio of 26.308 and a beta of 1.15.
Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $0.48 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.01. The firm earned $932 million during the quarter, compared to analyst estimates of $927.69 million. Xylem had a return on equity of 16.41% and a net margin of 9.22%. The business’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.43 earnings per share. On average, equities analysts predict that Xylem Inc. will post $2.04 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, September 21st. Investors of record on Wednesday, August 31st were paid a dividend of $0.1549 per share. This represents a $0.62 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date was Monday, August 29th. Xylem’s payout ratio is presently 33.16%.
XYL has been the topic of a number of research reports. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $52.00 price objective (up from $46.00) on shares of Xylem in a report on Monday, June 20th. Zacks Investment Research cut Xylem from a “buy” rating to a “hold” rating in a report on Friday, July 15th. Barclays PLC raised their price objective on Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a report on Monday, July 18th. Royal Bank Of Canada raised their price objective on Xylem from $47.00 to $51.00 and gave the company an “outperform” rating in a report on Tuesday, August 16th. Finally, RBC Capital Markets set a $51.00 price objective on Xylem and gave the company a “buy” rating in a report on Tuesday, August 16th. Nine research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Xylem has a consensus rating of “Hold” and a consensus price target of $45.00.
In related news, Director Steven R. Loranger sold 32,246 shares of the stock in a transaction that occurred on Thursday, July 28th. The stock was sold at an average price of $48.01, for a total transaction of $1,548,130.46. Following the completion of the transaction, the director now directly owns 38,334 shares of the company’s stock, valued at $1,840,415.34. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Colin R. Sabol sold 27,473 shares of the stock in a transaction that occurred on Thursday, September 8th. The shares were sold at an average price of $50.91, for a total value of $1,398,650.43. Following the transaction, the insider now directly owns 65,530 shares of the company’s stock, valued at $3,336,132.30. The disclosure for this sale can be found here. Corporate insiders own 0.77% of the company’s stock.
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.